Intranasal parainfluenza virus type 5 (PIV5)-vectored RSV vaccine is safe and immunogenic in healthy adults in a phase 1 clinical study
一项 I 期临床研究表明,鼻内接种的 5 型副流感病毒 (PIV5) 载体 RSV 疫苗在健康成人中安全且具有免疫原性。
期刊:Science Advances
影响因子:12.5
doi:10.1126/sciadv.adj7611
Spearman, Paul; Jin, Hong; Knopp, Kristeene; Xiao, Peng; Gingerich, Maria Cristina; Kidd, Jamie; Singh, Karnail; Tellier, Marinka; Radziewicz, Henry; Wu, Samuel; McGregor, Matthew; Freda, Barbara; Wang, Zhaoti; John, Susan P; Villinger, Francois J; He, Biao